Patient Release Criteria for Radioactive Iodine, 41442 [2020-14599]
Download as PDF
41442
Federal Register / Vol. 85, No. 133 / Friday, July 10, 2020 / Proposed Rules
(46) San Antonio-New BraunfelsPearsall, TX—consisting of the San
Antonio-New Braunfels-Pearsall, TX
CSA;
(47) San Diego-Carlsbad, CA—
consisting of the San Diego-Carlsbad,
CA MSA;
(48) San Jose-San Francisco-Oakland,
CA—consisting of the San Jose-San
Francisco-Oakland, CA CSA and also
including Monterey County, CA;
(49) Seattle-Tacoma, WA—consisting
of the Seattle-Tacoma, WA CSA and
also including Whatcom County, WA;
(50) St. Louis-St. Charles-Farmington,
MO-IL—consisting of the St. Louis-St.
Charles-Farmington, MO-IL CSA;
(51) Tucson-Nogales, AZ—consisting
of the Tucson-Nogales, AZ CSA and also
including Cochise County, AZ;
(52) Virginia Beach-Norfolk, VA-NC—
consisting of the Virginia BeachNorfolk, VA-NC CSA;
(53) Washington-Baltimore-Arlington,
DC-MD-VA-WV-PA—consisting of the
Washington-Baltimore-Arlington, DCMD-VA-WV-PA CSA and also including
Kent County, MD, Adams County, PA,
York County, PA, King George County,
VA, and Morgan County, WV; and
(54) Rest of U.S.—consisting of those
portions of the United States and its
territories and possessions as listed in 5
CFR 591.205 not located within another
locality pay area.
NUCLEAR REGULATORY
COMMISSION
Please refer to Docket ID
NRC–2020–0037 when contacting the
NRC about the availability of
information regarding this petition. You
may obtain publicly-available
information related to this action by any
of the following methods:
• Federal Rulemaking website: Go to
https://www.regulations.gov and search
for Docket ID NRC–2020–0037. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–415–3463;
email: Carol.Gallagher@nrc.gov. For
technical questions, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘Begin Web-based ADAMS Search.’’ For
problems with ADAMS, please contact
the NRC’s Public Document Room (PDR)
reference staff at 1–800–397–4209, 301–
415–4737, or by email to pdr.resource@
nrc.gov.
• Attention: The Public Document
Room (PDR), where you may examine
and order copies of public documents,
is currently closed. You may submit
your request to the PDR via email at
PDR.Resource@nrc.gov or call 1–800–
397–4209 between 8:00 a.m. and 4:00
p.m. (EST), Monday through Friday,
except Federal holidays.
10 CFR Part 35
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2020–14255 Filed 7–9–20; 8:45 am]
BILLING CODE 6325–39–P
[Docket No. PRM–35–21; NRC–2020–0037]
Patient Release Criteria for Radioactive
Iodine
Nuclear Regulatory
Commission.
ACTION: Petition for rulemaking;
withdrawal by petitioner.
AGENCY:
jbell on DSKJLSW7X2PROD with PROPOSALS
VerDate Sep<11>2014
17:00 Jul 09, 2020
Jkt 250001
Pamela Noto, Office of Nuclear Material
Safety and Safeguards, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001; telephone: 301–415–
6795, email: Pamela.Noto@nrc.gov.
On
November 15, 2019, the NRC received a
petition for rulemaking from Peter
Crane, on behalf of Sensible Controls on
Administrations of Radioactive Iodine,
requesting revision to the criteria in
§ 35.75 of title 10 of the Code of Federal
Regulations related to patient release
after the administration of radioactive
iodine. The NRC docketed the petition
on January 24, 2020 (Docket No. PRM–
35–21). On May 22, 2020, the petitioner
submitted a request to withdraw his
petition (ADAMS Accession No.
ML20143A159) given the COVID–19
public health emergency. The NRC
acknowledges withdrawal of the
petition and is closing Docket No. PRM–
35–21; NRC–2020–0037.
SUPPLEMENTARY INFORMATION:
The U.S. Nuclear Regulatory
Commission (NRC) is announcing the
withdrawal, without prejudice to a
future filing, of a petition for rulemaking
(PRM–35–21), dated November 15,
2019, filed by Peter Crane on behalf of
Sensible Controls on Administrations of
Radioactive Iodine. The petitioner
requested that the NRC revise its
regulations regarding the criteria for
patient release after the administration
of radioactive iodine. By letter dated
May 22, 2020, the petitioner withdrew
the petition.
DATES: The docket for PRM–35–21, is
closed on July 10, 2020.
SUMMARY:
ADDRESSES:
PO 00000
Dated: July 1, 2020.
Frm 00004
Fmt 4702
Sfmt 4702
For the Nuclear Regulatory Commission.
Annette L. Vietti-Cook,
Secretary of the Commission.
[FR Doc. 2020–14599 Filed 7–9–20; 8:45 am]
BILLING CODE 7590–01–P
FEDERAL DEPOSIT INSURANCE
CORPORATION
12 CFR Parts 303, and 347
RIN 3064–AF54
Branch Application Procedures
Federal Deposit Insurance
Corporation (FDIC).
ACTION: Proposed rule.
AGENCY:
The FDIC proposes to amend
its application requirements for the
establishment and relocation of
branches and offices so that such
applications would no longer require
statements regarding the compliance of
such proposals with the National
Historic Preservation Act of 1966
(NHPA) and the National Environmental
Policy Act of 1969 (NEPA). In
connection with an ongoing and
comprehensive review of the FDIC’s
existing regulations and guidance to
identify rules or guidance that may be
outdated, duplicative, or inconsistent,
and after a careful analysis of applicable
law, staff has concluded that continued
consideration of the NHPA and the
NEPA in the review of applications for
the establishment of a branch and
applications for the relocation of a
branch or main office is not required
under law and, therefore, consideration
of these statutes during the processing
of these applications is an unnecessary
regulatory requirement for insured state
nonmember banks and insured branches
of foreign banks. Accordingly, the FDIC
proposes to amend its regulations to
remove NHPA and NEPA requirements
embedded in its branch application
procedures, and to rescind its
statements of policy regarding the
NHPA and the NEPA, consistent with
branch application procedures for
national banks and insured state
member banks supervised by the Office
of the Comptroller of the Currency and
the Board of Governors of the Federal
Reserve System. These statements of
policy respectively provide guidance
regarding the FDIC’s consideration of
the NHPA and the NEPA in the context
of the FDIC’s review of applications for
deposit insurance for de novo
institutions, the establishment of
branches, and relocation domestic
branches or main offices.
DATES: Comments must be received on
or before August 10, 2020.
SUMMARY:
E:\FR\FM\10JYP1.SGM
10JYP1
Agencies
[Federal Register Volume 85, Number 133 (Friday, July 10, 2020)]
[Proposed Rules]
[Page 41442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-14599]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
10 CFR Part 35
[Docket No. PRM-35-21; NRC-2020-0037]
Patient Release Criteria for Radioactive Iodine
AGENCY: Nuclear Regulatory Commission.
ACTION: Petition for rulemaking; withdrawal by petitioner.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is announcing the
withdrawal, without prejudice to a future filing, of a petition for
rulemaking (PRM-35-21), dated November 15, 2019, filed by Peter Crane
on behalf of Sensible Controls on Administrations of Radioactive
Iodine. The petitioner requested that the NRC revise its regulations
regarding the criteria for patient release after the administration of
radioactive iodine. By letter dated May 22, 2020, the petitioner
withdrew the petition.
DATES: The docket for PRM-35-21, is closed on July 10, 2020.
ADDRESSES: Please refer to Docket ID NRC-2020-0037 when contacting the
NRC about the availability of information regarding this petition. You
may obtain publicly-available information related to this action by any
of the following methods:
Federal Rulemaking website: Go to https://www.regulations.gov and search for Docket ID NRC-2020-0037. Address
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: [email protected]. For technical questions, contact
the individual listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS
Search.'' For problems with ADAMS, please contact the NRC's Public
Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or
by email to [email protected].
Attention: The Public Document Room (PDR), where you may
examine and order copies of public documents, is currently closed. You
may submit your request to the PDR via email at [email protected] or
call 1-800-397-4209 between 8:00 a.m. and 4:00 p.m. (EST), Monday
through Friday, except Federal holidays.
FOR FURTHER INFORMATION CONTACT: Pamela Noto, Office of Nuclear
Material Safety and Safeguards, U.S. Nuclear Regulatory Commission,
Washington, DC 20555-0001; telephone: 301-415-6795, email:
[email protected].
SUPPLEMENTARY INFORMATION: On November 15, 2019, the NRC received a
petition for rulemaking from Peter Crane, on behalf of Sensible
Controls on Administrations of Radioactive Iodine, requesting revision
to the criteria in Sec. 35.75 of title 10 of the Code of Federal
Regulations related to patient release after the administration of
radioactive iodine. The NRC docketed the petition on January 24, 2020
(Docket No. PRM-35-21). On May 22, 2020, the petitioner submitted a
request to withdraw his petition (ADAMS Accession No. ML20143A159)
given the COVID-19 public health emergency. The NRC acknowledges
withdrawal of the petition and is closing Docket No. PRM-35-21; NRC-
2020-0037.
Dated: July 1, 2020.
For the Nuclear Regulatory Commission.
Annette L. Vietti-Cook,
Secretary of the Commission.
[FR Doc. 2020-14599 Filed 7-9-20; 8:45 am]
BILLING CODE 7590-01-P